Skip to main content
. 2016 Nov 18;3:2333794X16679587. doi: 10.1177/2333794X16679587

Table 1.

Demographic and Clinical Characteristics.

Total, n = 85 Control, n = 42 Prodefen®, n = 43 P
Age
 Mean ± SD, years 3.5 ± 3.2 3.6 ± 3.4 3.4 ± 3.1 0.803
 6 months to 2 years, n (%) 41 (48.2) 19 (45.2) 22 (51.2) 0.584
 3-5 years, n (%) 22 (25.9) 13 (31.0) 9 (20.9) 0.292
 6-12 years, n (%) 22 (25.9) 10 (23.8) 12 (27.9) 0.666
Sex (boys), n (%) 36 (42.4) 17 (40.5) 19 (44.2) 0.729
Weight (kg), median (IQR) 14.0 (10.1-20.5) 14.4 (9.5-21.2) 14.0 (10.3-20.0) 0.937
Height (cm), median (IQR) 98.0 (81.3-117.3) 98.0 (82.0-116.5) 93.0 (81.0-118.0) 0.943
BMI (kg/m2), median (IQR) 15.6 (14.8-16.6) 15.7 (14.6-16.6) 15.4 (14.8-16.8) 0.939
Abnormal physical examination, n (%) 4 (4.7) 2 (4.8) 2 (4.7) 0.999
Number of stools
 Median (IQR) 5 (3-6) 5 (3-6) 5 (4-6) 0.824
 ≥5 stools, n (%) 47 (55.3) 23 (54.8) 24 (55.8) 0.992
Symptoms,a n (%)
 No symptoms 12 (14.1) 8 (19.0) 4 (9.3) 0.175
 Fever 30 (35.3) 18 (42.9) 12 (27.9) 0.149
 Vomiting 25 (29.4) 13 (31.0) 12 (27.9) 0.758
 Mucus on stools 24 (28.2) 11 (26.2) 13 (30.2) 0.679
 Abdominal pain 55 (64.7) 23 (54.8) 32 (74.4) 0.058
Number of symptoms, median (IQR) 2 (1-2) 2 (1-3) 2 (1-2) 0.956

Abbreviations: IQR, interquartile range; BMI, body mass index.

a

Reported by at least 5% of the children.